CervoMed, Inc. (CRVO)
3.98
-0.01
(-0.25%)
USD |
NASDAQ |
Apr 17, 16:00
4.06
+0.08
(+2.01%)
After-Hours: 20:00
CervoMed SG&A Expense (Quarterly) : 2.51M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 12.30M |
| Curis, Inc. | 2.883M |
| Plus Therapeutics, Inc. | 4.168M |
| Windtree Therapeutics, Inc. | 1.855M |
| Halozyme Therapeutics, Inc. | 77.03M |